Quantum Surgical, an innovative surgical robotic company which is developing a unique mini-invasive surgery solution dedicated to liver cancer treatment, announces that it has been granted €200 000 by the Occitanie Region.
This investment grant financed by the Occitanie Region as part of a plan for local businesses, labeled “Pass Rebond Occitanie”, aims to support economic recovery following the Covid-19 health crisis.
This grant will enable the company to purchase and integrate an information system (Enterprise Resource Planning – ERP), prior to its first product sales dedicated to minimally invasive liver cancer treatment.
“We are extremely grateful for the support received from the Occitanie region, especially with the current Health crisis. This grant will help us pursuing our robotic platform development, which is scheduled to be commercially launched in 2021. “said Christophe Sibillin, C.F.O of Quantum Surgical.
Quantum Surgical in a few words
Co-founded in 2017 by Bertin Nahum, Quantum Surgical is an innovative surgical robotic company based in Montpellier (France). Quantum Surgical’s robotic solution is a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer. This platform combining robotics, image analytics, and artificial intelligence will allow more and more patients to benefit from safer interventional oncology procedures, especially in the case of early-stage liver cancers. The incidence of liver cancer in the population is, unfortunately, growing very rapidly. Liver cancer is one of the most common cancers with more than 800 000 cases each year in the world, of which 10,000 in France.
Further information is available on our website: https://quantumsurgical.com/